Αρχική World News ESMO Virtual Congress 2020, 19-21 September

ESMO Virtual Congress 2020, 19-21 September [ESMO Media Alert]

LUGANO, Switzerland – The ESMO Congress 2020 will be held as a virtual meeting, with the programme delivered over two weekends:

  • Science weekend on 19-21 September
  • Educational weekend on 16-18 October

ESMO welcomes media interested in reporting from the ESMO meetings and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form accredited media representatives will be able to access embargoed material and official press conferences.

The scientific programme will include the presentation of the latest cancer research results with more than 2100 abstracts, including around 100 expected late-breaking abstracts. Abstract titles are already listed in the online programme, the titles of accepted late-breaking abstracts will be made available at the end of August.

Please note the new embargo schedule for the ESMO Virtual Congress 2020:

  1. Abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Poster (suffix ‘P’, ‘TiP’) and EONS Poster (prefix ‘CN’) will be published online via the ESMO website at 00:05 CEST on Monday, 14 September 2020.
  2. Abstracts and late-breaking abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Mini Oral (suffix ‘MO’) will be published online via the ESMO website at 00:05 CEST on Friday, 18 September 2020.
  3. Abstracts and late-breaking abstracts accepted for presentation at the ESMO Virtual Congress 2020 as Proffered Paper (suffix ‘O’) and EONS Proffered Paper (prefix ‘CN’) will be published online via the ESMO website at 00:05 CEST on Saturday, 19 September 2020.
  4. Abstracts and late-breaking abstracts selected for inclusion in the ESMO Press Programme will be published online according to a dedicated schedule which will be made available by early September.
  • Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.
  • Data and information beyond what is included in all accepted abstracts, including full data sets and full manuscripts, may only be made public at the start of the official programme session during which the study is presented.

Media representatives are required to observe and abide by the ESMO Media Policy which applies to all ESMO meetings.

Further information

ESMO Press Office

media@esmo.org

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...

Easy Meals at Home

Our theme this week is delicious, easy to make, at home meals. These recipes minimize your cook time and maximize your food enjoyment. Ingredients 8...

This Saturday: National Prescription Drug Take-Back Day

Have you taken a look at your medicine cabinet lately? Aside from cotton swabs, mouthwash and makeup remover, are there old, outdated prescription drugs...

How People With Cancer Can Benefit From Online Therapy

Tanya J. Peterson, MS, is credentialed with the National Board of Certified Counselors. She is a regular contributor to the mental health website, Choosing...

EMA Recommends Granting a Conditional Marketing Authorisation for Autologous Anti-CD19-Transduced CD3+ Cells

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...

New Treatment Helps Survivors Regain Sensation After Breast Cancer

When NBC’s Kristen Dahlgren was diagnosed with breast cancer, she didn’t think much about the lack of sensation that her mastectomy would likely leave...